Sanders Ahead of Vote to Subpoena CEOs to Testify on Outrageously High Prices of Prescription Drugs in America
January 26, 2024
January 26, 2024
WASHINGTON, Jan. 26 -- Sen. Bernie Sanders, I-Vermont, issued the following news release on Jan. 25, 2024:
Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor, and Pension (HELP) today held a press conference to discuss the committee's decision to vote to issue subpoenas for Johnson & Johnson CEO Joaquin Duato and Merck CEO Robert Davis to provide testimony about why their companies charge substantially higher prices for medicine in the Unit . . .
Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor, and Pension (HELP) today held a press conference to discuss the committee's decision to vote to issue subpoenas for Johnson & Johnson CEO Joaquin Duato and Merck CEO Robert Davis to provide testimony about why their companies charge substantially higher prices for medicine in the Unit . . .